Healio (7/9, Gramigna) reported, “Several factors increased risk for stimulant treatment discontinuation and switch to nonstimulants among people with” attention-deficit/hyperactivity disorder (AD/HD), researchers concluded after analyzing “analyzing genetic and national register data of 9,133 individuals with” AD/HD. These factors “included having higher polygenic liability for mood and/or psychotic disorders, delayed ADHD diagnosis and psychiatric comorbidities.” The findings were published online June 22 in the American Journal of Psychiatry, a publication for the American Psychiatric Association.
Related Links:
— “Researchers identify factors that influence stimulant discontinuation, switch in ADHD “Joe Gramigna, Healio, July 9, 2021